Similar to these studies, we observed that treatment with NaHS in primary neonatal rat cardiomyocytes subjected to hyperglycemia, HR, or both conditions increased the activity and expression of PPAR-α (Figure 7A,B) as well as eNOS expression (Figure 9C). Here, NOS3 is linked to Hyperglycemia.